Currencies / REGN
REGN: Regeneron Pharmaceuticals Inc
554.58
USD
5.87
(1.05%)
REGN exchange rate has changed by -1.05% for today. During the day, the instrument was traded at a low of 550.49 and at a high of 563.59.
Follow Regeneron Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
REGN News
- Zacks Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
- Zacks Unlocking Q2 Potential of Regeneron (REGN): Exploring Wall Street Estimates for Key Metrics
- Investing Biotech stocks dip as Trump administration mulls patent fee overhaul
- Zacks Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
- The Motley Fool 2 Healthcare Stocks That Are Losing to the S&P 500 This Year
- Zacks Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- Zacks REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?
- Seeking Alpha Fidelity OTC Portfolio Q2 2025 Commentary (undefined:FOCPX)
- Seeking Alpha Fidelity Contrafund Q2 2025 Commentary (undefined:FCNTX)
- Zacks Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well
- TipRanks QQQ ETF News, 7/24/2025 - TipRanks.com
- Seeking Alpha Longleaf Partners Global Fund Q2 2025 Commentary (LLGLX)
- Benzinga Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
- Seeking Alpha Longleaf Partners Fund Q2 2025 Commentary (LLPFX)
- TipRanks QQQ ETF News, 7/22/2025 - TipRanks.com
- The Motley Fool After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
- Zacks Regeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?
- Investing H.C. Wainwright reiterates Buy rating on Harrow Health stock at $60 target
- TipRanks QQQ ETF News, 7/18/2025 - TipRanks.com
- Zacks BAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?
- Seeking Alpha Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff (AMGN)
- Investor's Business Daily Stock Market Today: Dow Falls As American Express Tumbles; Advanced Micro Leads Nasdaq Higher (Live Coverage)
- Seeking Alpha AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB)
- Investor's Business Daily Stock Market Holds At Record Highs Despite Trump Tariffs: Weekly Review
Daily Range
550.49
563.59
Year Range
476.48
1211.20
- Previous Close
- 558.14
- Open
- 560.45
- Bid
- 554.58
- Ask
- 554.88
- Low
- 550.49
- High
- 563.59
- Volume
- 1.001 K
- Daily Change
- -1.05%
- Month Change
- 5.84%
- 6 Months Change
- -17.09%
- Year Change
- -48.03%
31 July, Thursday
11:30
USD
- Act
- Fcst
- Prev
- 47.999 K
11:30
USD
- Act
- Fcst
- -68.3%
- Prev
- -1.6%
12:30
USD
- Act
- Fcst
- 0.4%
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 2.6%
- Prev
- 2.7%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.3%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- -0.1%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- -0.4%
12:30
USD
- Act
- Fcst
- 0.0%
- Prev
- -0.3%
12:30
USD
- Act
- Fcst
- 0.9%
- Prev
- 0.9%
12:30
USD
- Act
- Fcst
- 1.0%
- Prev
- 1.2%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- 0.8%
12:30
USD
- Act
- Fcst
- 224 K
- Prev
- 217 K
12:30
USD
- Act
- Fcst
- 1.966 M
- Prev
- 1.955 M
12:30
USD
- Act
- Fcst
- 222.299 K
- Prev
- 224.500 K
13:45
USD
- Act
- Fcst
- 42.4
- Prev
- 40.4
14:00
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.0%
14:30
USD
- Act
- Fcst
- 2 B
- Prev
- 23 B
15:30
USD
- Act
- Fcst
- Prev
- 4.245%
15:30
USD
- Act
- Fcst
- Prev
- 4.265%